Anterior Ameloblastoma, Masquerading a Residual Cyst: A Case Report
Main Article Content
Abstract
Background: Ameloblastoma is a benign odontogenic tumor of epithelial origin that exhibits a locally aggressive
behaviour with a high level of recurrence and multiple factors involved in its molecular pathogenesis. Anterior
ameloblastoma is a rare variant that makes up about 10% of all its varieties, presents unique difficulties
in diagnosis, especially while differentiating it from other lesions in anterior region. Its vivid range of clinical
manifestation further puzzles in clinical diagnosis and can complicate planning of surgeries and thereby affect
the prognosis. We highlight one such case which mimics a residual cyst and thus mandates importance of thorough
diagnostics.
Case Report: This case report presents a rare occurrence of ameloblastoma in anterior mandible of a 60-yearold
patient who reported a swelling in the lower anterior region, which had been present for 5-6 months and
was initially noticed two years ago when it was smaller. This case report aims to highlight the unusual location
of the tumor, the clinical and radiological findings and the treatment modalities employed.
Conclusion: Promptness in diagnosis and relevant treatment of ameloblastoma is crucial due to its malignant
potential and recurrence rate. It underscores the importance of early detection and intervention, which can
significantly improve patient prognosis and reduce the risk of recurrence. Further, it emphasizes the need for
regular follow-ups to monitor any risk of recurrence or any other complications.
Article Details

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
https://creativecommons.org/licenses/by-nc/2.0/deed.en
How to Cite
References
Effiom OA, Ogundana OM, Akinshipo AO, Akintoye SO.
Ameloblastoma: current etiopathological concepts
and management. Oral diseases. 2018 Apr;24(3):
-16.
Medina A, Velasco Martinez I, McIntyre B, Chandran R.
Ameloblastoma: clinical presentation, multidisciplinary
management and outcome. Case Reports in Plastic Surgery
and Hand Surgery. 2021 Jan 1;8(1):27-36.
Guan P, Wong SF, Lim JQ, Ng CC, Soong PL, Sim CQ, Ong CK,
Rajasegaran V, Myint SS, Lee JY, Tan HK. Mutational signatures
in mandibular ameloblastoma correlate with smoking.
Journal of Dental Research. 2019 Jun;98(6):652-8.
Brown NA, Rolland D, McHugh JB, Weigelin HC, Zhao
L, Lim MS, Elenitoba-Johnson KS, Betz BL. Activating
FGFR2–RAS–BRAF mutations in ameloblastoma. Clinical
Cancer Research. 2014 Nov 1;20(21):5517-26.
Sweeney RT, McClary AC, Myers BR, Biscocho J, Neahring
L, Kwei KA, Qu K, Gong X, Ng T, Jones CD, Varma S. Identification
of recurrent SMO and BRAF mutations in ameloblastomas.
Nature genetics. 2014 Jul;46(7):722-5.
. Heikinheimo K, Kurppa KJ, Elenius K. Novel targets for the
treatment of ameloblastoma [Internet]. Vol. 94, Journal
of Dental Research. SAGE Publications Inc.; 2015 [cited
Jun 30]. p. 237–40.
Titinchi F, Morkel J. Residual cyst of the jaws: A clinico-
pathologic study of this seemingly inconspicuous lesion.
Plos one. 2020 Dec 17;15(12):e0244250.
Kondamari SK, Taneeru S, Guttikonda VR, Masabattula GK.
Ameloblastoma arising in the wall of dentigerous cyst:
Report of a rare entity. Journal of oral and maxillofacial
pathology. 2018 Jan 1;22(Suppl 1):S7-10.
Krishnamurthy V, Haridas S, Garud M, Vahanwala S, Nayak
CD, Pagare SS. Radicular cyst masquerading as a multilocular
radiolucency. Quintessence International. 2013
Jan 1;44(1).
Fuchigami T, Ono Y, Kishida S, Nakamura N. Molecular
biological findings of ameloblastoma. Japanese Dental
Science Review. 2021 Nov 1;57:27-32.
Rayamajhi S, Shrestha S, Shakya S, Bhandari S, Twayana
AR, Shahi K. Unicystic ameloblastoma of mandible: A
case report. JNMA: Journal of the Nepal Medical Association.
Jul;60(251):657.
Ghai S. Ameloblastoma: an updated narrative review of
an enigmatic tumor. Cureus. 2022 Aug;14(8).
Malakar A, Kumar VR, Yadav P, Bhardwaj V, Barua CG,
Bhardwaj G. The Role of BRAF Inhibitors in the Management
of Ameloblastoma: A Literature Review. Cureus.
Oct;15(10).
Nguyen J, Saffari PS, Pollack AS, Vennam S, Gong X, West
RB, Pollack JR. New ameloblastoma cell lines enable preclinical
study of targeted therapies. Journal of Dental Research.
Nov;101(12):1517-25.